These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30008938)

  • 1. Hub genes and key pathways of non-small lung cancer identified using bioinformatics.
    Tang Q; Zhang H; Kong M; Mao X; Cao X
    Oncol Lett; 2018 Aug; 16(2):2344-2354. PubMed ID: 30008938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key candidate tumor biomarkers in non-small-cell lung cancer by
    Chen W; Zhu S; Zhang Y; Xiao J; Tian D
    Oncol Lett; 2020 Jan; 19(1):1008-1016. PubMed ID: 31897214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis.
    Zou Z; Gan S; Liu S; Li R; Huang J
    Oncol Lett; 2019 Jul; 18(1):916-926. PubMed ID: 31289570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis.
    Li Z; Sang M; Tian Z; Liu Z; Lv J; Zhang F; Shan B
    Oncol Lett; 2019 Nov; 18(5):4429-4440. PubMed ID: 31611952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
    Shi Y; Li Y; Yan C; Su H; Ying K
    Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
    Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
    Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
    Tu H; Li J; Xu W; Wang Z; Wang L
    Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key candidate genes and biological pathways in bladder cancer.
    Gao X; Chen Y; Chen M; Wang S; Wen X; Zhang S
    PeerJ; 2018; 6():e6036. PubMed ID: 30533316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially expressed genes and biological pathways in bladder cancer.
    Tang F; He Z; Lei H; Chen Y; Lu Z; Zeng G; Wang H
    Mol Med Rep; 2018 May; 17(5):6425-6434. PubMed ID: 29532898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
    Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
    Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival-based bioinformatics analysis to identify hub genes and key pathways in non-small cell lung cancer.
    Liu C; Chen Y; Deng Y; Dong Y; Jiang J; Chen S; Kang W; Deng J; Sun H
    Transl Cancer Res; 2019 Aug; 8(4):1188-1198. PubMed ID: 35116861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key genes and pathways in meningioma by bioinformatics analysis.
    Dai J; Ma Y; Chu S; Le N; Cao J; Wang Y
    Oncol Lett; 2018 Jun; 15(6):8245-8252. PubMed ID: 29805558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation.
    Yin Y; Li D; He M; Wang J
    Transl Cancer Res; 2022 Aug; 11(8):2622-2635. PubMed ID: 36093542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
    Wang W; Wang S; Pan L
    Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.
    Cui S; Lou S; Feng J; Tang X; Xiao X; Huang R; Guo W; Zhou Y; Huang F
    Transl Cancer Res; 2022 Apr; 11(4):710-724. PubMed ID: 35571642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray based analysis of gene regulation by mesenchymal stem cells in breast cancer.
    Zhang M; Gao CE; Li WH; Yang Y; Chang L; Dong J; Ren YX; Chen D
    Oncol Lett; 2017 Apr; 13(4):2770-2776. PubMed ID: 28454465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data.
    Liang F; Peng L; Ma YG; Hu W; Zhang WB; Deng M; Li YM
    Exp Ther Med; 2022 Jan; 23(1):6. PubMed ID: 34815758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.